Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats. - Wikidata - awgldk - TriplyDB

Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats.

Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats.

http://www.wikidata.org/entity/Q42537047

about

Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients.Novel CoQ10 antidiabetic mechanisms underlie its positive effect: modulation of insulin and adiponectine receptors, Tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats.Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway.Oxidation as an important factor of protein damage: Implications for Maillard reaction.Statins stimulate the production of a soluble form of the receptor for advanced glycation end products.Effects of methanolic extracts from edible plants on endogenous secretory receptor for advanced glycation end products induced by the high glucose incubation in human endothelial cells.Greater efficacy of atorvastatin versus a non-statin lipid-lowering agent against renal injury: potential role as a histone deacetylase inhibitor.Preventive effects of taurine against d-galactose-induced cognitive dysfunction and brain damage.Estimation of ellagic acid and/or repaglinide effects on insulin signaling, oxidative stress, and inflammatory mediators of liver, pancreas, adipose tissue, and brain in insulin resistant/type 2 diabetic rats.Efficacy of Subgingivally Delivered 1.2% Atorvastatin in the Treatment of Chronic Periodontitis in Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Clinical Trial.

P2860

Q33776181-8BB5CEF5-EF13-40AC-B75D-1A76BC4C610E Q35106778-BD42D3D0-B8C2-40E7-8714-6A50B2882141 Q36047141-A017BADA-5B60-4A63-8C60-12DE0BE2E1C6 Q37392958-D91B80DA-72E7-46A7-BDDB-58400565F8C5 Q38473579-67065806-A475-4CDB-A27A-57E3D5A65834 Q39106836-FFD70646-D83A-4308-9C91-59C5A7DED864 Q39684307-E7D67A93-CE62-444E-8150-340D753F2FCE Q42361500-6BC2807A-1428-45F9-875D-64469602E993 Q43167963-79E2B21D-3ACE-4853-9A7E-F46FE97B8894 Q46264282-0284BDA0-1C9A-4EE4-8C33-A46F8490183C Q53562629-46B42FD3-EF9E-45D9-A7F8-453759D10BC0

P2860

Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats.

http://www.wikidata.org/entity/Q42537047

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Effects of atorvastatin on pro ...... uble RAGE expressions in rats.

@en

Effects of atorvastatin on pro ...... uble RAGE expressions in rats.

@nl

type

label

Effects of atorvastatin on pro ...... uble RAGE expressions in rats.

@en

Effects of atorvastatin on pro ...... uble RAGE expressions in rats.

@nl

prefLabel

Effects of atorvastatin on pro ...... uble RAGE expressions in rats.

@en

Effects of atorvastatin on pro ...... uble RAGE expressions in rats.

@nl

P1433

Q42537047-58A90237-180A-4A86-BD0A-B62414078772

P1476

Q42537047-21D72F9D-B0F7-44E2-9F44-2B252EC1EAD2

P2093

Q42537047-04BDBB30-6B2A-4CB2-8DE5-DCBE16D4CA68

Q42537047-5EA1A063-5F0C-4CAA-B4B6-BBF2F4A74344

Q42537047-807A7A8C-A948-4803-93C6-9C570979F2E1

Q42537047-8B12CC44-C960-47B9-9BA2-23D8F07E0450

Q42537047-8B61848E-BF27-4516-AE0B-84AA5F99D669

Q42537047-9012A5B4-9706-4EEB-823C-48671642533C

P2860

Q42537047-00FAD9EA-7741-4EEA-9A54-6F779C1AFD22

Q42537047-02461916-C721-4905-B859-32BBDB1A35C0

Q42537047-140542DC-E0D3-4F6E-A072-BFD8714F448E

Q42537047-1DE95DE7-B4DD-45EF-98AF-B8921E728E3D

Q42537047-338FF263-BF97-4231-A40A-9DC9607607F4

Q42537047-3C1AF006-E86B-4F66-858D-0B059EA23B53

Q42537047-450863C0-A245-4428-9B07-8F6DF695DF96

Q42537047-4B83AB85-B1DE-472F-85E7-72C90127BA29

Q42537047-63FB9912-50B2-4887-8847-5F07D3DE982B

Q42537047-6C6DFB5B-8CF8-42F8-9149-393C6336FE25

P2888

Q42537047-6EB2A5ED-876B-4BE3-9D23-94A8DF1B9D89

P304

Q42537047-9F6ECE3E-732A-479C-92E1-675CC6FF2144

P31

Q42537047-A27ADC3A-772A-4C21-BB17-D8AF1756AE9D

P356

Q42537047-27DAB0D1-9476-4791-B4B8-796BAC20BFC7

P433

Q42537047-503B0DC2-0F2E-42EB-8889-02B2DB56EA9B

P478

Q42537047-2EB5109C-A50B-4F12-A43D-01B8FD347688

P577

Q42537047-ED610FD1-6C1E-4133-9CC2-27EA1A6828CD

P6179

Q42537047-7C8ACCE1-325F-4F5E-803A-B1C0841752E9

P698

Q42537047-91E76E4B-7E02-480A-B53E-2181A393111F

P932

Q42537047-634320A2-BAD4-4E7A-9C40-1EE78EAEC561

P356

P1433

Journal of Zhejiang University. Science. B

P1476

Effects of atorvastatin on pro ...... uble RAGE expressions in rats.

@en

P2093

Lin Lu

http://www.w3.org/2001/XMLSchema#string

Ling-Jie Wang

http://www.w3.org/2001/XMLSchema#string

Qiu-Jing Chen

http://www.w3.org/2001/XMLSchema#string

Wei Wang

http://www.w3.org/2001/XMLSchema#string

Wei-Feng Shen

http://www.w3.org/2001/XMLSchema#string

Wen-Hui Peng

http://www.w3.org/2001/XMLSchema#string

P2860

Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3

Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression

Advanced glycation end products: sparking the development of diabetic vascular injury.

Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.

Advanced glycation end products and the kidney.

Statins for improving renal outcomes: a meta-analysis.

Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.

Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.

Soluble forms of RAGE in human diseases: clinical and therapeutical implications.

Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.

P2888

P304

652-659

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1631/JZUS.B1101004

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1019538870

http://www.w3.org/2001/XMLSchema#string

P698

21796806

http://www.w3.org/2001/XMLSchema#string

P932

3150719

http://www.w3.org/2001/XMLSchema#string